After a brief reminder of recent progress in radiological methods in the diagnosis of mediastinal disorders, the authors study the contribution of Computerised Axial Tomography (T.D.M.). The advantages of T.D.M. in mediastinal disease rest on two characteristics : the morphological study of the mediastinum is made easier by the display of transverse axial cuts with nothing superimposed; the density measurements can distinguish between opacities which would appear similar on conventional radiology. Three facts have been established by the authors : T.D.M. raises the diagnostic sensitivity of radiology; in distinguishing between fatty, watery, vascular and solid tumours, it increases aetiological specificity; it simplifies the diagnostic approach while increasing the efficiency of radiology and the importance of its role in therapeutic decisions. In a typical case where one has just discovered an abnormal mediastinal opacity (and in whom a gastro-intestinal primary has been excluded), T.D.M. should be the first examination after standard radiography, because its results determine the remaining investigation. T.D.M. is specially indicated in evaluating a myasthenic or when investigating an anomaly in the infero-posterior mediastinum. A few cases do not entirely fit in to this schema, because of a particular clinical or radiological situation such as : mediastinal adenopathy; the assessement of the extent of a bronchogenic carcinoma; anterior cardio-phrenic opacities. The examination of the hila again has its limits when the abnormal opacity is small as there are errors in the technique due to the effects of incomplete volume. Finally, there remains the improved cost-effectiveness of the radiological examination of the mediastinum with the rational use of T.D.M.
Download full-text PDF |
Source |
---|
Drugs R D
January 2025
Department of Pediatric Intensive Care Unit, Shandong, Shandong Provincial Hospital Affiliated to Shandong First Medical University, 324 Jingwu Road, Ji'nan, Shandong, China.
Background And Objective: Alglucosidase alfa for injection is used as an enzyme replacement therapy for the treatment of Pompe disease. The safety profile of alglucosidase alfa-associated adverse events requires a comprehensive evaluation. In this study, we aimed to identify drug safety alert signals and investigate the real-world safety of alglucosidase alfa to guide clinical decision making and optimize the risk-benefit balance.
View Article and Find Full Text PDFBr J Hosp Med (Lond)
December 2024
Department of Respiratory and Critical Care Medicine, Tianjin Medical University General Hospital, Tianjin, China.
Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is the standard method for sampling mediastinal/hilar lymph node disease. However, the smaller samples obtained via needle aspiration have a lower diagnostic rate for benign compared to malignant diseases. The low diagnostic rates have been reported to be improved through using endobronchial ultrasound-guided intranodal forceps biopsy (EBUS-IFB), but the implementation of IFB presents technical challenges, as described with variable results in certain studies.
View Article and Find Full Text PDFJ Thorac Dis
December 2024
Department of Diagnostic Radiology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Chest computed tomography (CT) is the most frequently performed imaging examination worldwide. Compared with chest radiography, chest CT greatly improves the detection rate and diagnostic accuracy of chest lesions because of the absence of overlapping structures and is the best imaging technique for the observation of chest lesions. However, there are still frequently missed diagnoses during the interpretation process, especially in certain areas or "blind spots", which may possibly be overlooked by radiologists.
View Article and Find Full Text PDFExpert Opin Drug Saf
January 2025
Department of Pharmacy, Mianyang Central Hospital, School of Medicine, University of Electronic Science and Technology of China, Mianyang, Sichuan, China.
Background: Amivantamab has been approved for EGFR exon 20 insertion-mutated non-small-cell lung cancer. The aim of this study was to perform an in-depth analysis of its safety profile.
Research Design And Methods: Safety reports were collected from the database of the Food and Drug Administration Adverse Event Reporting System from April 2021 to September 2023, and the reporting odds ratio (ROR) method was used to detect potential safety signals.
BMJ Case Rep
January 2025
Department of Nephrology, Barts Health NHS Trust, London, UK.
Anti-neutrophil cytoplasmic antibody-associated vasculitides (AAV) represent a heterogeneous multisystem group of disorders typified by necrotising inflammation of smaller blood vessels, classically yielding a pauci-immune, crescentic glomerulonephritis. Without prompt treatment, there is a significant risk of irreversible damage and ensuing renal impairment.Diagnosis is often challenging, exacerbated by the disorder's often vague and insidious presentation.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!